Validation of the Turkish version of European Organization for Research and Treatment of Cancer QLQ-OV28 ovarian cancer specific quality of life questionnaire

dc.authorid0000-0002-8574-5065
dc.authorid0000-0002-3303-1343
dc.contributor.authorAkdemir, Yesim
dc.contributor.authorCam, Cetin
dc.contributor.authorAy, Nadiye Pinar
dc.contributor.authorKarateke, Ates
dc.date.accessioned2025-05-10T19:52:51Z
dc.date.issued2020
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: To examine reliability and validity of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-OV28 questionnaire into the Turkish language according to the instructions provided by EORTC. Materials and Methods: Ninety-seven patients who were diagnosed as having ovarian cancer and treated between January 2005 and June 2010 with an expected survival time of at least 3 months, were enrolled into the study. The exclusion criteria were diagnoses of any disease that could disrupt consciousness and concurrent malignancies. The EORTC QLQ-OV28 module was translated into Turkish by professional translators and physicians. The test-retest reliability of the Turkish version of the questionnaire was performed on 30 patients. Answers were scored according to the instructions provided by the EORTC. The total score was calculated as explained above and after scoring procedures, all subscale scores were linearly transformed to a 0-100 scale. All patients concomitantly completed the Spielberg State Trait Anxiety Inventory (STAI) and Beck Depression Inventory (BDI). Patients were analyzed in two groups: on-treatment and off-treatment groups consisted of patients who did and did not undergo chemotherapy or surgery within the last two months, respectively. The demographic data of all patients were recorded. EORTC QLQ-OV28 scores of both groups were compared. Correlations between EORTC QLQ-OV28 subscales and total score of BDI and STAI were analyzed. Results: For test-retest reliability, Spearman's rho was 0.84 (p<0.001). The on-treatment group scored statistically significantly higher than the off-treatment group in peripheral neuropathies, attitude to disease and treatment, sexual function and other chemotherapy adverse effect subscales of the questionnaire. Correlations between EORTC QLQ-OV28 subscales and the total scores of BDI and STAI of the groups were statistically significant, except the sexual function subscale. Conclusion: The Turkish translated version of EORTC QLQ-OV28 module is a reliable, consistent, and a valid instrument for assessing the impact of treatment modalities on QoL among Turkish speaking women with ovarian cancer.
dc.identifier.doi10.4274/tjod.galenos.2020.26594
dc.identifier.endpage57
dc.identifier.issn2149-9322
dc.identifier.issn2149-9330
dc.identifier.issue1
dc.identifier.pmid32341831
dc.identifier.scopus2-s2.0-85088999519
dc.identifier.scopusqualityQ3
dc.identifier.startpage52
dc.identifier.trdizinid427871
dc.identifier.urihttps://doi.org/10.4274/tjod.galenos.2020.26594
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/427871
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12564
dc.identifier.volume17
dc.identifier.wosWOS:000523674600009
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherGalenos Yayincilik
dc.relation.ispartofTurkish Journal of Obstetrics and Gynecology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectQuality of life
dc.subjectovarian cancer
dc.subjectEORTC
dc.titleValidation of the Turkish version of European Organization for Research and Treatment of Cancer QLQ-OV28 ovarian cancer specific quality of life questionnaire
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12564.pdf
Boyut:
109.29 KB
Biçim:
Adobe Portable Document Format